Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is desi... Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol. Show more
– Product Revenues, Net Expected in the Range of $735 Million to $750 Million – – Jornay PM® Net Revenue Expected to be in Excess of $135 Million – – Adjusted EBITDA* Expected in the Range of...
STOUGHTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...
– Generated Record Q3’24 Net Revenue of $159.3 Million, Up 17% Year-over-Year, Driven by Record Belbuca® Revenue of $53.2 Million and Record Xtampza® ER Revenue of $49.5 Million – – Achieved...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.91 | -2.71641791045 | 33.5 | 33.73 | 32.54 | 347273 | 32.97733806 | CS |
4 | 3.28 | 11.1907198908 | 29.31 | 33.99 | 28.39 | 454835 | 31.56929828 | CS |
12 | -1.72 | -5.01311570971 | 34.31 | 35.62 | 28.39 | 486935 | 31.01020461 | CS |
26 | -1.135 | -3.36545589325 | 33.725 | 42.23 | 28.39 | 439667 | 34.25559742 | CS |
52 | -0.56 | -1.68929110106 | 33.15 | 42.23 | 28.39 | 442495 | 34.44761802 | CS |
156 | 15.12 | 86.5483686319 | 17.47 | 42.23 | 14.04 | 377862 | 27.18179314 | CS |
260 | 10.94 | 50.5311778291 | 21.65 | 42.23 | 13 | 384738 | 24.62286432 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales